| mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
3e-08 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
5e-07 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-06 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-06 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-06 |
| mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
4e-06 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
5e-06 |
| mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
6e-06 |
| mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
6e-06 |
| mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
6e-06 |